Refuerzo:

Si recibió la serie de vacunas Moderna:

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.

Si recibió la serie de vacunas de Pfizer:

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
El refuerzo de Pfizer solo está disponible para personas mayores de 12 años.

Si recibió la vacuna Janssen (Johnson & Johnson):

Puede recibir una dosis de refuerzo de Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

BOOSTER Shot:

If you received the Moderna vaccine series:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 5 months after your second dose or additional dose.

If you received the Pfizer vaccine series:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 5 months after your second dose or additional dose.
The Pfizer booster is only available for people who are 12 years of age and older.

If you received the Janssen (Johnson & Johnson) vaccination:

You can receive a booster dose of Janssen (Johnson & Johnson) or Pfizer 2 months after your vaccination.
The Janssen (Johnson & Johnson) booster is only available for people who are 18 years of age and older.

Si recibió la serie de vacunas de Pfizer:

• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
• El refuerzo de Pfizer solo está disponible para personas mayores de 12 años.

Si recibió la vacuna Janssen (Johnson & Johnson):
• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
• El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

Pfizer (12-17) Additional Dose Qualifiers

Active cancer treatment for tumors or cancers of the blood
Organ transplant recipients who are taking medicine to suppress the immune system
Stem cell transplant recipients (within the last 2 years or taking immunosuppressive medications)
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection

Si recibió la vacuna Janssen (Johnson & Johnson):

• Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 2 meses después de la vacunación.
• El refuerzo de Janssen (Johnson & Johnson) solo está disponible para personas mayores de 18 años.

Si recibió la serie de vacunas Moderna:

Puede recibir una dosis de refuerzo de Moderna, Janssen (Johnson & Johnson) o Pfizer 5 meses después de su segunda dosis o dosis adicional.
El refuerzo Moderna solo está disponible para personas mayores de 18 años.

Calificadores de dosis adicionales

Los estudios mostraron respuestas inmunitarias inadecuadas a solo dos dosis en personas con las siguientes condiciones:

Tratamiento oncológico activo para tumores o cánceres de la sangre
Receptores de trasplantes de órganos que toman medicamentos para inhibir el sistema inmunitario
Receptores de trasplantes de células madre (en los últimos 2 años o tomando medicamentos inmunosupresores)
Inmunodeficiencia primaria moderada o grave (como el síndrome de DiGeorge, el síndrome de Wiskott-Aldrich)
Infección avanzada o no tratada de VIH
Tratamiento activo con dosis altas de cortico-esteroides (p. ej., cortisona, prednisona) u otros medicamentos que pueden suprimir su respuesta inmunitaria.
Si tiene alguna pregunta sobre si debe recibir una dosis adicional, comuníquese con su proveedor de atención médica.

NOTA: Si no ha completado su serie de dos dosis, su dosis adicional se puede programar al recibir su segunda vacunación.

Qualifying Medical Condition

Cancer (current or in remission, including 9/11-related cancers);
Chronic kidney disease;
Pulmonary Disease, limited to, COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), pulmonary fibrosis, cystic fibrosis, tuberculosis, and 9/11 related pulmonary diseases;
Intellectual and Developmental Disabilities including Down
Syndrome;
Heart conditions, including but not limited to heart failure, coronary artery disease, cardiomyopathies, or hypertension (high blood pressure);
Immunocompromised state (weakened immune system) including but not limited to solid organ transplant or from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medicines, or other causes;
Severe Obesity (BMI 40 kg/m2 or higher), Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2), Overweight (BMI of 25 kg/m2 or higher but < 30kg/m2);
Pregnant or recently pregnant;
Sickle cell disease or Thalassemia;
Type 1 or 2 diabetes mellitus;
Cerebrovascular disease (affects blood vessels and blood supply to the brain);
Neurologic conditions include but not limited to Alzheimer’s
Disease or dementia;
Liver disease limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, or autoimmune hepatitis;
Current or former smoker;
Substance use disorder,
Mental health disorders are limited to mood disorders including depression, schizophrenia spectrum disorders.

Qualifying Medical Condition

Cancer (current or in remission, including 9/11-related cancers);
Chronic kidney disease;
Pulmonary Disease, limited to, COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), pulmonary fibrosis, cystic fibrosis, tuberculosis, and 9/11 related pulmonary diseases;
Intellectual and Developmental Disabilities including Down
Syndrome;
Heart conditions, including but not limited to heart failure, coronary artery disease, cardiomyopathies, or hypertension (high blood pressure);
Immunocompromised state (weakened immune system) including but not limited to solid organ transplant or from blood or bone marrow transplant, immune deficiencies, HIV, use of corticosteroids, use of other immune weakening medicines, or other causes;
Severe Obesity (BMI 40 kg/m2 or higher), Obesity (body mass index [BMI] of 30 kg/m2 or higher but < 40 kg/m2), Overweight (BMI of 25 kg/m2 or higher but < 30kg/m2);
Pregnant or recently pregnant;
Sickle cell disease or Thalassemia;
Type 1 or 2 diabetes mellitus;
Cerebrovascular disease (affects blood vessels and blood supply to the brain);
Neurologic conditions include but not limited to Alzheimer’s
Disease or dementia;
Liver disease limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, or autoimmune hepatitis;
Current or former smoker;
Substance use disorder,
Mental health disorders are limited to mood disorders including depression, schizophrenia spectrum disorders.

Additional Dose Qualifiers

Studies showed inadequate immune responses to only two doses in people with the following conditions:

Active cancer treatment for tumors or cancers of the blood
Organ transplant recipients who are taking medicine to suppress the immune system
Stem cell transplant recipients (within the last 2 years or taking immunosuppressive medications)
Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
Advanced or untreated HIV infection
Active treatment with high-dose corticosteroids (e.g. cortisone, prednisone) or other drugs that may suppress your immune response.
If you have a question about whether you should receive an additional dose, please contact your health care provider.

NOTE: If you have not completed your two-dose series, your additional dose can be scheduled at the completion of your second vaccination.

NY Community Broadband Partnership

This RFP for NYCBP seeks increased internet / ethernet connections at 1 site from CASA-Trinity, 7 sites from ConnextCare, 6 sites from Family Health Network, 3 sites from Mosaic Health, and 9 Finger Lakes Community Health sites, which currently have inadequate broadband connectivity for their needs.

The services requested will provide connectivity to each site as specified in the RFP and network diagram attached. The configuration must support QoS, specifically DSCP prioritization end to end for telehealth and secure reliable connections for electronic HIE.

The Rural Health Care Program

The Rural Health Care (RHC) Program supports health care facilities in bringing world-class medical care to rural areas through increased connectivity. It provides up to $400 million annually in reduced rates for broadband and telecom services. There are two subprograms in the RHC Program: the Healthcare Connect Fund (HCF) Program and the Telecommunications (Telecom) Program.

The NY Community Broadband Partnership (NYCBP)

The NY Community Broadband Partnership (NYCBP) was formed as a part of the Federal Communications Commission (FCC) Healthcare Connect Program (HCP). The HCP promotes the creation of rural consortiums of healthcare organizations for the development of broadband infrastructure for healthcare providers in rural underserved communities. The consortium can be comprised of rural and urban healthcare partners and is designated rural if there is a 51% or greater representation of rural partners.

NYCBP welcomes rural and urban partners from the communities of New York State to the consortium. All eligible partners will get a 65% discount in their monthly cost for broadband services offered by an Internet Services Provider (ISP) chosen by the consortium. The partners will pay a small subscription fee to NYCBP for the administration and management of the consortium activities.

Questions and Answers

Is it possible to waive the hard copy and supply an electronic copy?

No, 1 electronic copy and 1 hard copy are required by the RFP.

Can the electronic file be emailed?

Yes, please email to rachelm@flchealth.org.

Are these sites receiving dedicated fiber internet, and if so, what is the bandwidth requirements per site?

Please refer to the form 461 for requested bandwidths for all sites.

Are you also looking for firewalls for each Internet circuit?

The firewalls are requested only for the FLCH sites.

Will you be extending the deadline to receive bids?

Yes, the deadline has been extended to 3/20/26.

Our Vision

To be the provider of choice for comprehensive healthcare and an advocate for services that improve the quality of life for everyone in our community.

*The Federal Tort Claims Act (FTCA) to HRSA-supported health centers. Under the Act, health centers are considered Federal employees and are immune from lawsuits, with the Federal government acting as their primary insurer.

Refuerzo:

Si recibió la serie de vacunas Moderna: